Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Sitagliptin 100 mg Tablets relative to Januvia 100 mg Tablets in healthy Thai volunteers under fasting condition
TCTR20220318005Phase 1Not yet recruiting
- Sponsor
- Umeda Seiyaku
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin (2 arms), sponsored by Umeda Seiyaku. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20220318005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220318005.